⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic esophageal carcinoma

Every month we try and update this database with for metastatic esophageal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsNCT02757391
Colorectal Aden...
Metastatic Chol...
Metastatic Colo...
Metastatic Dige...
Metastatic Esop...
Metastatic Gast...
Metastatic Panc...
Stage IV Colore...
Stage IV Esopha...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Color...
Stage IVB Color...
Adoptive Immuno...
Aldesleukin
Cyclophosphamid...
Laboratory Biom...
Pembrolizumab
18 Years - M.D. Anderson Cancer Center
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsNCT05038254
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Colo...
Metastatic Esop...
Metastatic Gast...
Metastatic Live...
Metastatic Mali...
Metastatic Mali...
Metastatic Mali...
Metastatic Panc...
Metastatic Rect...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage IV Colon ...
Stage IV Hepato...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Small ...
Stage IVA Colon...
Stage IVA Hepat...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Hepat...
Stage IVB Recta...
Stage IVC Colon...
Stage IVC Recta...
Best Practice
Patient Monitor...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerNCT06251973
Metastatic Esop...
Advanced Unrese...
Metastatic Gast...
Metastatic Gast...
Metastatic Esop...
Metastatic Esop...
Metastatic Gast...
Metastatic Gast...
Unresectable Es...
Unresectable Es...
Unresectable Ga...
Unresectable Ga...
Unresectable Ga...
AgenT-797
Botensilimab
Balstilimab
Ramucirumab
Paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersNCT04221893
Stage IV Esopha...
Stage IV Esopha...
Stage IV Gastri...
Stage IV Adenoc...
Stage IVA Esoph...
Stage IVA Esoph...
Stage IVA Gastr...
Stage IVA Adeno...
Stage IVB Esoph...
Stage IVB Esoph...
Stage IVB Gastr...
Stage IVB Gastr...
Metastatic Anal...
Metastatic Colo...
Metastatic Esop...
Metastatic Gast...
Metastatic Gast...
Metastatic Hepa...
Metastatic Mali...
Metastatic Smal...
Pancreatobiliar...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage IV Anal C...
Stage IV Colore...
Stage IV Hepato...
Stage IVA Color...
Stage IVA Hepat...
Stage IVB Color...
Stage IVB Hepat...
Stage IVC Color...
Radiation Thera...
18 Years - University of California, San Francisco
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by SurgeryNCT03008278
Metastatic Esop...
Metastatic Gast...
Metastatic Gast...
Recurrent Esoph...
Recurrent Gastr...
Recurrent Gastr...
Stage III Esoph...
Stage III Gastr...
Stage IV Esopha...
Stage IV Gastri...
Unresectable Es...
Unresectable Ga...
Unresectable Ga...
Olaparib
Ramucirumab
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: